BioPharmSignal logoBioPharmSignal

Biotech News

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Hyperfine (HYPR)HyperfineEarnings

GUILFORD, Conn. --(BUSINESS WIRE)--Mar. 18, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth

Open original release

Related news

HYPRHyperfine2026-05-12 20:05 EST

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

HYPRHyperfine2026-04-28 20:05 EST

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

XAIRBeyond Air2026-06-26 11:00 EST

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

XTNTXtant Medical2026-03-31 11:00 EST

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

IRIXIRIDEX2026-03-26 20:05 EST

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

XTNTXtant Medical2026-03-25 12:00 EST

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

STIMNeuronetics2026-03-17 11:50 EST

Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

IRIXIRIDEX2026-03-12 20:05 EST

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

View all latest news

Hyperfine

Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.

Recent company news

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

HYPRHyperfine2026-06-22 12:15 EST

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

HYPRHyperfine2026-06-18 12:15 EST

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

HYPRHyperfine2026-05-26 12:15 EST

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

HYPRHyperfine2026-05-22 12:15 EST

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Stock data

Close
0.96 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States